Specify a stock or a cryptocurrency in the search bar to get a summary
Bioretec Oy
0TNBioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. Bioretec Ltd. was incorporated in 1998 and is headquartered in Tampere, Finland. Address: Yrittäjänkulma 5, Tampere, Finland, 33710
Analytics
WallStreet Target Price
2.79 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 0TN
Dividend Analytics 0TN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0TN
Stock Valuation 0TN
Financials 0TN
Results | 2019 | Dynamics |